Genetic risk variants that have been identified in genome-wide association studies of complex diseases are primarily non-coding(1). Translating these risk variants into mechanistic insights requires detailed maps of gene regulation in disease-relevant cell types(2). Here we combined two approaches: a genome-wide association study of type 1 diabetes (T1D) using 520,580 samples, and the identification of candidate cis-regulatory elements (cCREs) in pancreas and peripheral blood mononuclear cells using single-nucleus assay for transposase-accessible chromatin with sequencing (snATAC-seq) of 131,554 nuclei. Risk variants for T1D were enriched in cCREs that were active in T cells and other cell types, including acinar and ductal cells of the exocrine pancreas. Risk variants at multiple T1D signals overlapped with exocrine-specific cCREs that were linked to genes with exocrine-specific expression. At the CFTR locus, the T1D risk variant rs7795896 mapped to a ductal-specific cCRE that regulated CFTR; the risk allele reduced transcription factor binding, enhancer activity and CFTR expression in ductal cells. These findings support a role for the exocrine pancreas in the pathogenesis of T1D and highlight the power of large-scale genome-wide association studies and single-cell epigenomics for understanding the cellular origins of complex disease.
Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.
利用遗传学和单细胞表观基因组学解读 1 型糖尿病风险
阅读:3
作者:Chiou Joshua, Geusz Ryan J, Okino Mei-Lin, Han Jee Yun, Miller Michael, Melton Rebecca, Beebe Elisha, Benaglio Paola, Huang Serina, Korgaonkar Katha, Heller Sandra, Kleger Alexander, Preissl Sebastian, Gorkin David U, Sander Maike, Gaulton Kyle J
| 期刊: | Nature | 影响因子: | 48.500 |
| 时间: | 2021 | 起止号: | 2021 Jun;594(7863):398-402 |
| doi: | 10.1038/s41586-021-03552-w | 研究方向: | 细胞生物学 |
| 疾病类型: | 糖尿病 | ||
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
